Bert van Loo
Impact in
- Pharmacology top 2%
- Pharmacological Effects of Natural Compounds
- Pharmacogenetics and Drug Metabolism
- Microbial Natural Products and Biosynthesis
- Biochemistry top 5%
Papers in
-
- Enzyme Catalysis and Immobilization 9
- Microbial Metabolic Engineering and Bioproduction 6
- Biochemical and Molecular Research 5
-
- Carbohydrate Chemistry and Synthesis 4
- Co-authors
- Florian Hollfelder (13 shared papers)Jaap Kingma (4 shared papers)Dick B. Janssen (4 shared papers)Marcel Wubbolts (2 shared papers)Marko Hyvönen (5 shared papers)Stefanie Jonas (4 shared papers)Wilfried Α. König (1 shared paper)Michiel H. A. Janssen (1 shared paper)
- Journals
- Biochemistry (2 papers)Journal of Molecular Biology (2 papers)Proceedings of the National Academy of Sciences (2 papers)FEBS Letters (2 papers)ACS Synthetic Biology (1 paper)
- Partner nations
- United KingdomGermanyNetherlands
In The Last Decade
Bert van Loo
20 papers receiving 836 citations
Peers
Comparison fields: 5 of 72
- Pharmacology 166
- Biochemistry 91
- Biotechnology 93
- Molecular Biology 684
- Pharmacology 88
Countries citing papers authored by Bert van Loo
This map shows the geographic impact of Bert van Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert van Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert van Loo more than expected).
Fields of papers citing papers by Bert van Loo
This network shows the impact of papers produced by Bert van Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert van Loo. The network helps show where Bert van Loo may publish in the future.
Co-authors
The 25 scholars most cited alongside Bert van Loo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 228 | |
| 2 | 2004 | 108 | |
| 3 | 2006 | 99 | |
| 4 | 2010 | 85 | |
| 5 | 2008 | 56 | |
| 6 | 2018 | 38 | |
| 7 | 2002 | 34 | |
| 8 | 2018 | 33 | |
| 9 | 2008 | 29 | |
| 10 | 2013 | 28 | |
| 11 | 2019 | 25 | |
| 12 | 2012 | 24 | |
| 13 | 2011 | 22 | |
| 14 | 2017 | 15 | |
| 15 | 2018 | 12 | |
| 16 | 2019 | 10 | |
| 17 | 2013 | 6 | |
| 18 | 2022 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2008 | 1 |
About Bert van Loo
Bert van Loo is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Endocrinology, Diabetes and Metabolism and Physiology, having authored 23 papers that have together received 861 indexed citations. Recurring topics across this work include Enzyme Catalysis and Immobilization (9 papers), Microbial Metabolic Engineering and Bioproduction (6 papers), Biochemical and Molecular Research (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Lysosomal Storage Disorders Research (4 papers), Alkaline Phosphatase Research Studies (4 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Trypanosoma species research and implications (2 papers). The work is most often cited by research in Pharmacology (166 citations), Biochemistry (91 citations), Biotechnology (93 citations), Molecular Biology (684 citations) and Pharmacology (88 citations). Bert van Loo has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include Florian Hollfelder, Jaap Kingma, Dick B. Janssen, Marcel Wubbolts, Marko Hyvönen, Stefanie Jonas, Wilfried Α. König, Michiel H. A. Janssen, Maarten A. Posthumus and Claus O. Schmidt. Their work appears in journals such as Biochemistry, Journal of Molecular Biology, Proceedings of the National Academy of Sciences, FEBS Letters and ACS Synthetic Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.